Omega-6 Amafutha Acids

-Delile

• Kungenzeka kungasebenzi ku ...
• Ubufakazi obanele bokukala ukusebenza kwe ...
• Ukuqapha okukhethekile nezixwayiso:

Ama-omega-6 fatty acids yizinhlobo zamafutha. Ezinye izinhlobo zitholakala kumafutha wemifino, kufaka phakathi ummbila, imbewu yantambama ye-primrose, i-safflower, namafutha kabhontshisi. Ezinye izinhlobo zama-omega-6 fatty acids zitholakala embewini emnyama emnyama, imbewu ye-borage, nakoyela wakusihlwa we-primrose.

Ama-omega-6 fatty acids asetshenziselwa izimo eziningi, kepha kuze kube manje, imininingwane engcono kakhulu isayensi engayinikeza ukuthi ukubeka i-arachidonic acid, i-omega-6 fatty acid ethile, kwifomula yezinsana ayikuthuthukisi ukukhula kwezinsana. Alukho ucwaningo olwanele olwenziwe kuma-omega-6 fatty acids ukwahlulela ukuthi ayasebenza yini kwezinye izindlela.

Ulwazi oluningi esinalo kuma-omega-6 fatty acid supplements luvela ekutadisheni ama-omega-6 fatty acids athile noma amafutha ezitshalo aqukethe i-omega-6 fatty acids. Bona izinhlu ezihlukile ze-gamma linolenic acid, kanye ne-evening primrose, i-borage ne-black currant.

Imibhalo Yemvelo Yemininingwane Ephelele ukukala ukusebenza ngokuncike ebufakazini besayensi ngokwesilinganiso esilandelayo: Okusebenzayo, Okungenzeka Kusebenze, Okungenzeka Kusebenze, Okungenzeka Kungasebenzi, Cishe Okungaphumeleli, Ukungasebenzi, Nobufakazi Obunganele Bokulinganisa.

Izilinganiso zokusebenza ze I-OMEGA-6 FATTY ACIDS zimi kanje:

Kungenzeka kungasebenzi ku ...

• Isifo senhliziyo. Ucwaningo oluningi lukhombisa ukuthi ukudla okuphezulu kwama-omega-6 fatty acids akwehlisi ubungozi besifo senhliziyo noma imicimbi emibi ehlobene nenhliziyo. Kunobunye ubufakazi bokuthi izinhlobo ezahlukahlukene ze-omega-6 fatty acids zingathinta inhliziyo nemithambo yegazi ngokuhlukile. Kepha lokhu kusadingeka ukuqinisekiswa.
• Ukukhula kwengane. Ukungeza i-omega-6 fatty acid arachidonic acid kanye ne-omega-3 fatty acid ebizwa nge-docosahexaenoic acid (DHA) kwifomula yezinsana akubonakali kuthuthukisa ukukhula kwengqondo, umbono, noma ukukhula ezinganeni.
• I-Multiple sclerosis (MS). Ukuthatha i-omega-6 fatty acids akubonakali kuvimbela ukuqhubeka kwe-MS.

Ubufakazi obanele bokukala ukusebenza kwe ...

• Nciphisa amakhono wokukhumbula nokucabanga okwenzeka ngokujwayelekile ngobudala. Ucwaningo lwakuqala luphakamisa ukuthi abantu abane-omega-6 enamafutha acid amaningi emzimbeni wabo noma abadla i-omega-6 fatty acid eningi ekudleni bangahle babe nethuba lokwehla kwenkumbulo namakhono okucabanga ngobudala.
• Ukunakwa kokushoda-i-hyperactivity disorder (ADHD). Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha inhlanganisela ye-omega-3 kanye ne-omega-6 fatty acids kabili nsuku zonke izinyanga ezi-3-6 akuzithuthukisi izimpawu ze-ADHD.
• Ukuvuvukala kwejwabu leso (i-blepharitis). Abantu abadla inani elilinganisiwe lama-omega-6 fatty acids babonakala benengozi engezansi yokuthuthukisa uhlobo oluthile lokuvuvukala kwejwabu leso. Kodwa ukudla inani eliphakeme kakhulu akubonakali kusiza. Ukuthatha isengezo se-omega-6 fatty acid kungasiza ekuthuthukiseni izimpawu ezinjengokugqama kwabantu abanokuvuvukala kwejwabu leso. Kepha ucwaningo lwekhwalithi ephezulu luyadingeka ukuqinisekisa.
• Ukuphazamiseka kwamakhono ezimoto okuphawulwe ukungahambi kahle (ukuthuthuka kokuxhumanisa ukuphazamiseka noma iDCD). Ucwaningo lwakuqala luphakamisa ukuthi ukuthatha inhlanganisela yama-omega-6 nama-omega-3 fatty acids izinyanga ezintathu kungathuthukisa ukufunda, ukupela, nokuziphatha, kepha hhayi ukuhlangana noma ukunyakaza ezinganeni ezine-DCD.
• Isifo sikashukela. Abantu abanesilinganiso esiphakeme se-omega-6 fatty acid emzimbeni wabo mancane amathuba okuthi babe nesifo sikashukela kunabantu abanamanani aphansi. Kodwa ukuthola ama-omega-6 fatty acids amaningi kwizithasiselo noma ekudleni kubonakala kunganciphisi ubungozi besifo sikashukela.
• Uhudo. Ucwaningo lwakuqala lukhombisa ukuthi izingane ezisencane zondla ifomula eyengezwe nge-omega-6 fatty acid ebizwa nge-arachidonic acid kanye ne-omega-3 fatty acid ebizwa nge-docosahexaenoic acid (DHA) ngonyaka wokuqala wokuphila inengcuphe ephansi yohudo.
• Iso elomile. Ukudla okuphezulu kwama-omega-6 fatty acids akuxhumene nengozi encishisiwe yeso elomile.
• Umfutho wegazi ophezulu. Abantu abanempilo abadla ama-acid amaningi e-omega-6 angaba nengozi ephansi yokuthola umfutho wegazi ophezulu. Kodwa ukudla okuphezulu kokudla kwama-omega-6 fatty acids kuye kwaxhunyaniswa nengozi eyengeziwe yomfutho wegazi ophakeme kubantu abanesifo sikashukela.
• Ukubuyiselwa ekuhlinzweni kwamehlo laser (photoreactive keratectomy). Ucwaningo lwakuqala lukhombisa ukuthi ukuthatha ama-omega-6 fatty acids kanye ne-beta-carotene namavithamini B kungasiza ekululameni ekuhlinzweni kwamehlo kwelaser.
• Ukutheleleka kwemigwaqo yomoya. Ucwaningo lwakuqala lukhombisa ukuthi izingane ezisencane zondla ifomula eyengezwe nge-omega-6 fatty acid ebizwa nge-arachidonic acid kanye ne-omega-3 fatty acid ebizwa nge-docosahexaenoic acid (DHA) ngonyaka wokuqala wokuphila inengcuphe ephansi yokutheleleka emoyeni.
• Ukwehlisa amazinga amabi we-cholesterol (LDL).
• Ukwandisa amazinga amahle e-cholesterol (HDL).
• Ukunciphisa ingozi yomdlavuza.
• Ezinye izimo.

Kudingeka ubufakazi obuningi ukukala ukusebenza kwe-omega-6 fatty acids kulokhu kusetshenziswa.

Ama-omega-6 fatty acids atholakala yonke indawo emzimbeni. Basiza ngokusebenza kwawo wonke amaseli. Uma abantu bengadli i-omega-6 fatty acids eyanele, amaseli ngeke asebenze kahle. Ama-omega-6 fatty acids amaningi angashintsha indlela amaseli asabela ngayo futhi abe nemiphumela eyingozi kumaseli enhliziyweni nasemithanjeni yegazi.

Lapho ithathwa ngomlomo: Omega-6 fatty acids kukhona CISHE UVIKILE lapho kudliwe ngabantu abadala nezingane ezingaphezu kwezinyanga eziyi-12 njengengxenye yokudla ngamanani aphakathi kuka-5% no-10% wama-calories ansuku zonke. Kodwa-ke, akukho lwazi olwanele olutholakalayo lokwazi ukuthi ama-omega-6 fatty acids aphephile ukusetshenziswa njengomuthi.

Ukuqapha okukhethekile nezixwayiso:

Ukukhulelwa nokuncelisa ibele: Omega-6 fatty acids kukhona CISHE UVIKILE lapho kudliwe njengengxenye yokudla ngamanani aphakathi kuka-5% no-10% wama-calories ansuku zonke. Ukufakwa okuphezulu kukhona MHLAWUMBI ANGIPHEPHILE njengoba zingakhuphula ubungozi bokuthola usana oluncane kakhulu noma ukuba nengane ene-eczema. Alukho ulwazi olwanele olunokwethenjelwa ukwazi ukuthi ama-omega-6 fatty acid supplements aphephile yini ukusetshenziswa uma ukhulelwe noma uncelisa ibele. Hlala ohlangothini oluphephile futhi ugweme ukusetshenziswa.

Isifo samaphaphu esenza kube nzima ukuphefumula (isifo esingapheliyo sokuphazamiseka kwamaphaphu noma i-COPD): I-Omega-6 fatty acids ingenza ukuphefumula kube nzima kakhulu kubantu abane-COPD. Ungasebenzisi i-omega-6 fatty acids uma une-COPD.

Isifo sikashukela: Ukudla okuphezulu kwama-omega-6 fatty acids ekudleni kungakhuphula ubungozi bokuthola umfutho wegazi ophezulu kubantu abanesifo sikashukela. Kuze kube yilapho kwaziwa okuningi, ungasebenzisi izithako ze-omega-6 fatty acid uma unesifo sikashukela.

Ama-triglycerides aphezulu (uhlobo lwamafutha): I-Omega-6 fatty acids ingakhuphula amazinga e-triglyceride. Ungasebenzisi i-omega-6 fatty acids uma ama-triglycerides akho ephezulu kakhulu.

Akwaziwa ukuthi lo mkhiqizo uyaxhumana yini nemithi ethile.

Ngaphambi kokuthatha lo mkhiqizo, khuluma nodokotela wakho wezempilo uma usebenzisa noma imiphi imithi.

Akukho ukuxhumana okwaziwayo ngamakhambi nezengezo.

Akukho ukuxhumana okwaziwayo nokudla.

Umthamo ofanele we-omega-6 fatty acids uncike ezicini eziningana ezifana nobudala bomsebenzisi, impilo, kanye nezinye izimo eziningana. Ngalesi sikhathi alukho ulwazi olwanele lwesayensi ukunquma uhla olufanele lwamanani we-omega-6 fatty acids. Khumbula ukuthi imikhiqizo yemvelo ayihlali iphephile njalo futhi imithamo ingabaluleka. Qiniseka ukuthi ulandela izinkomba ezifanele kumalebula womkhiqizo futhi uthintane nosokhemisi wakho noma udokotela noma omunye uchwepheshe wezokunakekelwa kwempilo ngaphambi kokusebenzisa.

Ama-Acides Gras Essentiels N-6, Acides Gras Oméga-6, Acides Gras Omégas 6, Acides Gras Polyinsaturés, Acidos Grasos Omega 6, AGE, AGPI, Huiles d'Oméga 6, N-6, N-6 EFAs, N-6 Okubalulekile Amafutha Acids, Omega 6, Omega-6 Polyunsaturated Fatty Acids, Omega 6 Oils, Polyunsaturated Fatty Acids, PUFAs.

Ukuze ufunde kabanzi ngokuthi le ndatshana ibhalwe kanjani, sicela ubheke ifayela le- Imibhalo Yemvelo Yemininingwane Ephelele indlela.

1. UGardner KG, uGebretsadik T, uHartman TJ, et al. I-omega-3 ne-omega-6 ye-polyunsaturated fatty acids ngaphambi kokuzalwa kanye ne-atopic dermatitis yobuntwana. J Ukungezwani komzimba ne-Immunol Pract. 2020; 8: 937-944. Buka okungaqondakali.
2. UDong X, Li S, Chen J, Li Y, Wu Y, Zhang D. Inhlangano yokudla ω-3 kanye no-ω-6 okunamafutha acid adla ngokusebenza kwengqondo kubantu abadala: Ucwaningo Lukazwelonke Lwezempilo kanye Nokunakekelwa Kwezokudla (NHANES) 2011-2014 . Umsoco J. 2020; 19:25. Buka okungaqondakali.
3. UBrown TJ, uBrainard J, Ingoma F, et al. I-Omega-3, i-omega-6, kanye namafutha e-polyunsaturated aphelele wokuvikela nokwelashwa kohlobo lwe-2 yesifo sikashukela: ukubuyekezwa okuhlelekile nokuhlaziywa kwe-meta-kwezivivinyo ezilawulwa ngokungahleliwe. BMJ. 2019; 366: l4697. Buka okungaqondakali.
4. Henderson G, Crofts C, Schofield G. Linoleic acid kanye nokuvimbela isifo sikashukela. ILancet Isifo Sikashukela i-Endocrinol. 2018; 6: 12-13. Buka okungaqondakali.
5. I-Assmann KE, i-Adjibade M, i-Hercberg S, i-Galan P, i-Kesse-Guyot E. Ukudla okunamafutha okungafakwanga ngesikhathi sokuphila kuhlotshaniswa kahle nomsebenzi wokuqonda wakamuva kubantu abadala abanemiphumela yokuguqula ukwengeza kwe-antioxidant. J Umsoco. 2018; 148: 1938-1945. Buka okungaqondakali.
6. UZiemanski JF, uWolters LR, uJones-Jordan L, uNichols JJ, uNichols KK. Ubudlelwano phakathi kokudla okune-fatty acid okudliwayo kanye nesifo samehlo esomile nokungasebenzi kahle kwendlala ye-meibomian kwabesifazane be-postmenopausal. Ngingu-J Ophthalmol. I-2018; 189: 29-40. Buka okungaqondakali.
7. URutting S, uPapanicolaou M, Xenaki D, et al. Ukudla? -6 polyunsaturated fatty acid arachidonic acid kwandisa ukuvuvukala, kepha kuvimbela ukubonakaliswa kwamaprotheni e-ECM ku-COPD. Ukuphefumula Res. I-2018; 19: 211. Buka okungaqondakali.
8. UNakamura H, Hara A, Tsujiguchi H, et al. Ubudlelwano phakathi kokudla okune-n-6 okunamafutha acid kanye nomfutho wegazi ophezulu: Umphumela wamazinga we-hemoglobin we-glycated. Izakhamzimba. 2018; 10. pii: E1825. Buka okungaqondakali.
9. IHarris WS, iTintle NL, iRamachandran VS. I-Erythrocyte n-6 fatty acids kanye nengozi yemiphumela yenhliziyo nokufa okuphelele esifundweni senhliziyo seFramingham. Izakhamzimba. 2018; 10. pii: E2012. Buka okungaqondakali.
10. UHooper L, Al-Khudairy L, Abdelhamid AS, et al. Amafutha e-Omega-6 wokuvimbela okuyisisekelo nokwesibili kwesifo senhliziyo. ICochrane Database Syst Rev. 2018; 11: CD011094. Buka okungaqondakali.
11. UJasani B, Simmer K, Patole SK, Rao SC. Amaketanga amade we-polyunsaturated fatty acid anezelwa ezinganeni ezizalwe ngesikhathi. ICochrane Database Syst Rev 2017; 3: CD000376. Buka okungaqondakali.
12. UMoon K, uRao SC, uSchulzke SM, uPatole SK, uSimmer K. Longchain polyunsaturated fatty acid supplementation ezinganeni ezizalwe ngaphambi kwesikhathi. ICchrane Database Syst Rev 2016; 12: CD000375. Buka okungaqondakali.
13. UDelgado GE, März W, uLorkowski S, von Schacky C, uKleber ME. Ama-omega-6 fatty acids: izinhlangano eziphikisayo ezinobungozi-Ingozi yeLudwigshafen kanye neCardiovascular Health Study. UJ Clin Lipidol 2017; 11: 1082-90.e14. Buka okungaqondakali.
14. ULemoine Soto CM, Woo H, uRomero K, et al. Inhlangano ye-omega-3 ne-omega-6 fatty acid engayisebenzisa ngokuvuvukala kanye nemiphumela yokuphefumula ku-COPD. Ngingu-J J Cr Cr Care Care Med. 2018; 197: A3139.
15. I-Pawelczyk T, i-Trafalska E, i-Pawelczyk A, i-Kotlicka-Antczak M. Umehluko ku-omega-3 kanye ne-omega-6 polyunsaturated fatty acid ukusetshenziswa kwabantu abasengozini ephezulu kakhulu ye-psychosis, i-episode-schizophrenia yokuqala, kanye nokulawula okunempilo. Isikhathi sokuqala se-Psychiatry 2017; 11: 498-508. Buka okungaqondakali.
16. Wu JHY, Marklund M, Imamura F, Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Fatty Acids kanye Nemiphumela Research Consortium (FORCE). I-Omega-6 fatty acid biomarkers kanye nohlobo lwesigameko sesifo sikashukela esingu-2: ukuhlaziywa okuhlanganisiwe kwedatha esezingeni ngalinye yabantu abadala abangama-39? 740 abavela ezifundweni ezingama-20 ezizoba ngamaqoqo. ILancet Isifo Sikashukela Endocrinol 2017; 5: 965-74. Buka okungaqondakali.
17. U-Lee E, uKim H, uKim H, uHa EH, u-Chang N. Inhlangano ye-omega-6 fatty acid yokudla komama ngemiphumela yokuzalwa kwezinsana: AmaKorea Omama kanye neMpilo Yezemvelo Yezingane (MOCEH). Umsoco J 2018; 17: 47. Buka okungaqondakali.
18. Lapillonne A, Pastor N, Zhuang W, Scalabrin DMF. Izinsana zondla ifomula ngamakhemikhali anamafutha asetshenziwe amafinyela amade anciphise izehlakalo zezifo zokuphefumula kanye nohudo ngonyaka wokuqala wokuphila. BMC Pediatr. 2014; 14: 168. Buka okungaqondakali.
19. Socha, P., Koletzko, B., Swiatkowska, E., Pawlowska, J., Stolarczyk, A., noSocrha, J. Essential fatty acid metabolism ezinganeni ezine-cholestasis. I-Acta Paediatr. 1998; 87: 278-283. Buka okungaqondakali.
20. UGodley, P.A., Campbell, M.K, Gallagher, P., Martinson, F. E., Mohler, J. L., noSandler, R. S. Biomarkers wokusetshenziswa okunamafutha acid nobungozi be-prostatic carcinoma. I-Cancer Epidemiol. AmaBiomarkers Okwangaphambilini. 1996; 5: 889-895. Buka okungaqondakali.
21. Peck, MD, Mantero-Atienza, E., Miguez-Burbano, MJ, Lu, Y., Fletcher, MA, Shor-Posner, G., noBaum, MK Iphrofayili ye-plasma fatty eqinisekisiwe ishintshiwe ekuqaleni kwe-HIV-1 ukutheleleka. I-Lipids 1993; 28: 593-597. Buka okungaqondakali.
22. UGibson, R. A., Teubner, J. K., Haines, K., Cooper, D. M., noDavidson, G. P. Ubudlelwano phakathi kokusebenza kwamaphaphu kanye namazinga e-plasma fatty acid ezigulini ze-cystic fibrosis. UJ Pediatr Gastroenterol Nutriti 1986; 5: 408-415. Buka okungaqondakali.
23. I-Tso, P. ne-Hayashi, H. I-physiology kanye nokulawulwa kokufakwa kwamathumbu nokuthuthwa kwe-omega-3 ne-omega-6 fatty acids. Ummeli Prostaglandin Thromboxane Leukot. 1989; 19: 623-626. Buka okungaqondakali.
24. URaz, R. noGabis, L. Ama-acid abalulekile nama-deficit-hyperactivity disorder: ukubuyekeza okuhlelekile. I-Dev.Med Ingane Neurol. U-2009; 51: 580-592. Buka okungaqondakali.
25. Harris, WS, Mozaffarian, D., Rimm, E., Kris-Etherton, P., Rudel, LL, Appel, LJ, Engler, MM, Engler, MB, kanye no-Sacks, F. Omega-6 fatty acids kanye nengozi isifo senhliziyo nemithambo yegazi: ukwelulekwa kwesayensi okuvela kwikomidi elincane le-American Heart Association Nutrition loMkhandlu Wezomsoco, Umsebenzi Womzimba, kanye neMetabolism; Umkhandlu Wezobuhlengikazi Benhliziyo; kanye noMkhandlu we-Epidemiology and Prevention. Ukusakazwa 2-17-2009; 119: 902-907. Buka okungaqondakali.
26. Querques, G., Russo, V., Barone, A., Iaculli, C., noDelle, Noci N. [Ukusebenza kwe-omega-6 ukwelashwa kwamafutha acid ngaphambi nangemva kwe-photorefractive keratectomy]. UJ Fr Ophtalmol. 2008; 31: 282-286. Buka okungaqondakali.
27. Simopoulos, A. P. Isilinganiso se-omega-6 / omega-3 fatty acid, ukuhlukahluka kofuzo, nesifo senhliziyo. I-Asia Pac. J Clin Nutr 2008; 17 Isigaba 1: 131-134. Buka okungaqondakali.
28. U-Laidler, P., Dulinska, J., noMrozicki, S. Ngabe ukuvinjelwa kwenkulumo ye-c-myc kuyalamula umsebenzi wokulwa nesimila wama-ligands we-PPAR emigqeni yomdlavuza wesibeletho? I-Arch.I-Biochemys.I-Biophys. 6-1-2007; 462: 1-12. Buka okungaqondakali.
29. Nielsen, AA, Nielsen, JN, Gronbaek, H., Eivindson, M., Vind, I., Munkholm, P., Brandslund, I., noHey, H. Impact of enteral supplements ahlanganiswe nama-omega-3 fatty acids futhi / noma i-omega-6 fatty acids, i-arginine ne-ribonucleic acid ehlanganisiwe emazingeni e-leptin kanye nesimo sokudla okunempilo kwesifo sikaCrohn esisebenzayo eselashwa nge-prednisolone. Ukugaya ukudla 2007; 75: 10-16. Buka okungaqondakali.
30. UPinna, A., uPiccinini, P., noCarta, F. Umphumela we-oral linoleic ne-gamma-linolenic acid ekungasebenzi kahle kwe-meibomian gland. ICornea 2007; 26: 260-264. Buka okungaqondakali.
31. Sonestedt, E., Gullberg, B., noWirfalt, E. Kokubili ukuguqulwa komkhuba wokudla esikhathini esedlule futhi isimo sokukhuluphala kungathinta ukuhlangana phakathi kwezici zokudla kanye nomdlavuza webele we-postmenopausal. Umsoco Wezempilo Yomphakathi 2007; 10: 769-779. Buka okungaqondakali.
32. UMartinez-Ramirez, M. J., Palma, S., Martinez-Gonzalez, M. A., Delgado-Martinez, A. D., de la Fuente, C., noDelgado-Rodriguez, M.Ukudla kwamafutha kanye nobungozi bokuqhekeka kwe-osteoporotic kubantu asebekhulile. I-Eur.J Clin Nutriti 2007; 61: 1114-1120. Buka okungaqondakali.
33. UFarinotti, M., Simi, S., Di, Pietrantonj C., McDowell, N., Brait, L., Lupo, D., noFilippini, G. Ukungenelela kokudla kwe-multiple sclerosis. I-Cochrane.Database.Syst.Rev 2007; CD004192. Buka okungaqondakali.
34. Okuyama, H., Ichikawa, Y., Sun, Y., Hamazaki, T., and Lands, WE Cancers ezivamile e-USA zivuselelwa yi-omega 6 fatty acids kanye nenani elikhulu lamafutha ezilwane, kepha zicindezelwe yi-omega 3 fatty acids kanye ne-cholesterol. Ukudla Komhlaba Umfu. 2007; 96: 143-149. Buka okungaqondakali.
35. UMamalakis, G., Kiriakakis, M., Tsibinos, G., Hatzis, C., Flouri, S., Mantzoros, C., noKafatos, A. Ukudangala kanye ne-serum adiponectin kanye ne-adipose omega-3 kanye ne-omega-6 fatty acids ebusheni. I-Pharmacol.I-Biochem.I-Behav. 2006; 85: 474-479. Buka okungaqondakali.
36. UHughes-Fulford, M., Tjandrawinata, R. R., Li, C. F., no-Sayyah, S. Arachidonic acid, i-omega-6 fatty acid, ikhuthaza i-cytoplasmic phospholipase A2 kumaseli e-prostate carcinoma. ICarcinogenesis 2005; 26: 1520-1526. Buka okungaqondakali.
37. IGrimble, R. F. Ukungakhucululwa komzimba. I-Curr Opin. I-Gastroenterol 2005; 21: 216-222. Buka okungaqondakali.
38. UChiplonkar, S. A., Agte, V. V., Tarwadi, K. V., Paknikar, K. M., noDiwate, U. P. Micronutrient deficiices as predisposing of hypertension in lacto-vegetarian older Indian. UJ Am Coll. Nutrut 2004; 23: 239-247. Buka okungaqondakali.
39. Ama-Assies, J., Lok, A., Bockting, CL, Weverling, GJ, Lieverse, R., Visser, I., Abeling, NG, Duran, M., and Schene, AH Fatty acids namazinga e-homocysteine ​​ezigulini eziphindaphindayo ukudangala: isifundo sokuhlola somshayeli. I-Prostaglandins Leukot.Essent.Amafutha Acids 2004; 70: 349-356. Buka okungaqondakali.
40. UMelnik, B. noPlewig, G. Ngabe ukuphazamiseka kwe-omega-6-fatty acid metabolism kuyabandakanyeka ku-pathogenesis ye-atopic dermatitis? I-Acta Derm. Venereol.Suppl (Stockh) 1992; 176: 77-85. Buka okungaqondakali.
41. URichardson, A. J., Cyhlarova, E., noRoss, M. A. Omega-3 kanye ne-omega-6 fatty concentrations ezingxenyeni ezibomvu zamangqamuzana egazi zihlobene nezici ze-schizotypal kubantu abadala abaphilile. I-Prostaglandins Leukot.Essent.Amafutha Acids 2003; 69: 461-466. Buka okungaqondakali.
42. I-Cunnane, S. C. Izinkinga ngama-fatty acids abalulekile: isikhathi separadigm entsha? I-Lipid Res 2003; i-42: 544-568. Buka okungaqondakali.
43. UMunoz, S. E., Piegari, M., Guzman, C. A., no-Eynard, A. R. Imiphumela ehlukile ye-Oenothera yokudla, i-Zizyphus mistol, namafutha ommbila, kanye nokushoda kwe-fatty acid ekuqhubekeni kwe-murine mammary gland adenocarcinoma. Ukudla okunomsoco 1999; 15: 208-212. Buka okungaqondakali.
44. UHodge, L., Salome, CM, Hughes, JM, Liu-Brennan, D., Rimmer, J., Allman, M., Pang, D., Armor, C., noWoolcock, AJ Umphumela wokudla i-omega -3 no-omega-6 fatty acids ngobukhulu be-asthma ezinganeni. Ukuphefumula kwe-Eur. J 1998; 11: 361-365. Buka okungaqondakali.
45. UVentura, H. O., Milani, R. V., Lavie, C. J., Smart, F. W., Stapleton, D. D., Toups, T. S., and Price, H. L. Cyclosporine-induced hypertension. Ukusebenza kwama-omega-3 fatty acids ezigulini ngemuva kokufakwa komzimba. Ukusakazwa kuka-1993; 88 (5 Pt 2): II281-II285. Buka okungaqondakali.
46. UMargolin, G., Huster, G., Glueck, CJ, Speirs, J., Vandegrift, J., Illig, E., Wu, J., Streicher, P., noTracy, T. Umfutho wegazi wehla ezifundweni ezindala. : isifundo se-crossover esiphindwe kabili se-omega-3 ne-omega-6 fatty acids. Ngingu-J J Nutriti 1991; 53: 562-572. Buka okungaqondakali.
47. UJohnson, M., Ostlund, S., Fransson, G., Kadesjo, B., noGillberg, C. Omega-3 / omega-6 fatty acids wokunaka ukungabi namandla kokuphazamiseka kwengqondo: isilingo esilawulwa ngokungahleliwe ezinganeni nasebusheni . Ukungezwani. U-2009; 12: 394-401. Buka okungaqondakali.
48. U-Aupperle, R. L., Denney, D. R., Lynch, S. G., Carlson, S. E., noSullivan, D. K. Omega-3 fatty acids kanye ne-multiple sclerosis: ubudlelwane nokudangala. UJ Behav Med. 2008; 31: 127-135. Buka okungaqondakali.
49. I-Conklin, S. M., Manuck, S. B., Yao, J. K., Flory, J. D., Hibbeln, J. R., and Muldoon, M. F. High omega-6 kanye ne-omega-3 fatty acids ehlotshaniswa nezimpawu zokudangala kanye ne-neuroticism. I-Psychosom. 2007; 69: 932-934. Buka okungaqondakali.
50. Yamada, T., Strong, JP, Ishii, T., Ueno, T., Koyama, M., Wagayama, H., Shimizu, A., Sakai, T., Malcom, GT, noGuzman, MA Atherosclerosis kanye ne-omega -3 fatty acids kubantu bendawo yokudoba kanye nedolobhana lokulima eJapan. I-Atherosclerosis 2000; 153: 469-481. Buka okungaqondakali.
51. UColter, A. L., Cutler, C., noMeckling, K. A. Isimo se-fatty acid nezimpawu zokuziphatha zokunaka ukungasebenzi kahle kwentsha: isifundo sokulawulwa kwamacala. Umsoco J 2008; 7: 8. Buka okungaqondakali.
52. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwezithenjwa Zezokudla Zamandla, I-Carbohydrate. Fibre, Amafutha, Amafutha Acids, Cholesterol, Amaphrotheni, kanye nama-Amino Acids. IWashington, DC: National Academy Press, 2005. Itholakala ku: http://www.nap.edu/books/0309069351/html/
53. URichardson AJ, Montgomery P. Ucwaningo lwe-Oxford-Durham: isivivinyo esingahleliwe, esilawulwayo sokwengeza kokudla okunamafutha acid ezinganeni ezinenkinga yokuthuthuka kokuxhumanisa. Izifo zezingane 2005; 115: 1360-6. Buka okungaqondakali.
54. IBhodi Yezokudla Nezokudla, Isikhungo Sezokwelapha. Ukufakwa Kwereferensi Yezokudla Yamandla, i-Carbohydrate, iFibre, Amafutha, Amafutha Acids, Cholesterol, Amaphrotheni, kanye nama-Amino Acids (Macronutrients). Washington, DC: National Academy Press, 2002. Itholakala ku: http://www.nap.edu/books/0309085373/html/.
55. INewcomer LM, King IB, Wicklund KG, iStanford JL. Ukuhlangana kwamafutha acid nomdlavuza wendlala. IProstate 2001; 47: 262-8. Buka okungaqondakali.
56. ILeventhal LJ, uBoyce EG, uZurier RB. Ukwelashwa kwesifo samathambo nge-gammalinolenic acid. U-Ann Intern Med 1993; 119: 867-73. Buka okungaqondakali.
57. UNoguchi M, uRose DP, u-Earashi M, uMiyazaki I. Indima yama-fatty acids kanye ne-eicosanoid synthesis inhibitors ku-breast carcinoma. I-Oncology 1995; 52: 265-71. Buka okungaqondakali.
58. URose DP. Isizathu sokubamba iqhaza ekusekeleni ukuvimbela umdlavuza wokudla. Okwedlule Med 1996; 25: 34-7. Buka okungaqondakali.
59. UMalloy MJ, uKane JP. Ama-ejenti asetshenziswa ku-hyperlipidemia. Ku: B. Katzung, ed. I-Pharmacology Eyisisekelo Nemitholampilo. Umhla wesi-4. INorwald, CT: I-Appleton neLange, ngo-1989.
60. UGodley PA. Ukusetshenziswa kwamafutha acid okubalulekile kanye nengozi yomdlavuza webele. Ukuphathwa Komdlavuza Webele 1995; 35: 91-5. Buka okungaqondakali.
61. IGibson RA. Ama-acids ama-polyunsaturated amakhemikhali amade kanye nokuthuthukiswa kwezinsana (kokuhlela). ILancet 1999; 354: 1919.
62. ULucas A, uStafford M, uMorley R, et al. Ukusebenza nokuphepha kwe-chain chain ende ye-polyunsaturated fatty supplementation yobisi lwefomula yezingane: isilingo esingahleliwe. ILancet 1999; 354: 1948-54. Buka okungaqondakali.

Kugcine ukubuyekezwa - 11/19/2020